Global Drug Delivery Devices Market Size, Overview and Forecast by 2032
The
global Drug Delivery Devices Market size was valued at USD 20.64 Billion in 2022
and is projected to have a rapid revenue CAGR of 8% during the forecast period.
Several factors are driving the growth of the market, including the rising
prevalence of chronic diseases such as cancer, cardiovascular diseases, and
diabetes, increasing need for self-administration and home healthcare
equipment, technological advancements in drug delivery devices, and rising
demand for biologics and biosimilars.
Additionally,
the need to cut healthcare expenses due to the rising prevalence of needlestick
injuries and the increasing adoption of cutting-edge technology including
implantable, wearable, and networked drug delivery systems are further driving
market revenue growth. However, factors such as high costs of medicine delivery
systems, the absence of reimbursement policies in developing nations, and
strict regulatory criteria for approval of drug delivery devices are
restraining market revenue growth.
Get a sample PDF of the report, visit
@
https://www.reportsanddata.com/download-free-sample/6242
Based
on product type, the market is segmented into injectors, inhalers, pumps,
transdermal patches, and others. The injectors market accounted for the largest
revenue share in 2022 due to the rising prevalence of chronic illnesses such as
diabetes, cancer, and autoimmune conditions. In addition, the development of
sophisticated injectors such as auto injectors and pen injectors that provide
mobility, ease of use, and self-administration capabilities is expected to
drive revenue growth of this segment.
The
inhalers segment is expected to register a fast revenue growth rate due to the
rising prevalence of respiratory conditions such as asthma, Chronic Obstructive
Pulmonary Disease (COPD), and cystic fibrosis, while the pumps segment is
expected to account for a significantly large revenue share during the forecast
period due to the increasing use of pumps for drug administration in various
therapeutic fields, including oncology, pain treatment, and diabetes.
To know more about the latest insights
of the report, visit @
https://www.reportsanddata.com/request-latest-insight/6242
Key companies in the drug delivery
devices market –
There
are several key companies operating in the drug delivery devices market,
including:
·
Johnson &
Johnson
·
Novartis AG
·
Pfizer Inc.
·
Bayer AG
·
Roche Holding AG
·
GlaxoSmithKline
plc
·
Medtronic plc
·
Becton, Dickinson
and Company
·
3M Company
·
Cipla Inc.
Based
on end-use, the market is segmented into hospitals, home care, Ambulatory
Surgical Centers (ASCs), and others. The hospitals segment is expected to
register the fastest revenue growth rate due to increasing prevalence of
chronic diseases and patient population, and rising demand for cutting-edge
drug delivery systems.
The
home care segment is expected to account for a significantly large revenue
share due to the increasing elderly population and prevalence of chronic
diseases and the rising trend of self-administration of medications. The ASCs
segment is also expected to experience significant growth due to technological
developments in drug delivery methods and the rising number of surgical
procedures performed in ASCs.
Overall,
the global drug delivery devices market is expected to experience significant
growth due to the increasing prevalence of chronic diseases, rising demand for
biologics and biosimilars, technological advancements in drug delivery devices,
and the need for self-administration and home healthcare equipment. However,
factors such as high costs of medicine delivery systems, absence of
reimbursement policies in developing nations, and strict regulatory criteria
for approval of drug delivery devices could restrain market revenue growth.
Request a customized copy of the
report @
https://www.reportsanddata.com/request-customization-form/6242
Thank you for reading our report. To inquire
about customization or any query about the report, please get in touch with us.
Our team will make sure the report is best suited to your needs.
About Reports and
Data
Reports and Data is
a market research and consulting company that provides syndicated research
reports, customized research reports, and consulting services. Our solutions
purely focus on your purpose to locate, target, and analyze consumer behavior
shifts across demographics, across industries, and help clients to make smarter
business decisions. We offer market intelligence studies ensuring relevant and
fact-based research across multiple industries, including Healthcare, Touch
Points, Chemicals, Products, and Energy. We consistently update our research
offerings to ensure our clients are aware of the latest trends existent in the
market. Reports and Data has a strong base of experienced analysts from varied
areas of expertise. Our industry experience and ability to develop a concrete
solution to any research problems provides our clients with the ability to
secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Comments
Post a Comment